CTT1403

CTT1403 · Cancer Targeted Technology

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CTT1403, covering 2024-03-21 to 2024-03-21. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer [Phase 1]